Mary Ann Liebert, Inc., publishers has announced the appointment of Dr. Rodolphe Barrangou as Editor-in-Chief of The CRISPR Journal. Launching in early 2018, The CRISPR Journal will be the definitive journal for everything CRISPR and will serve as a central forum dedicated to bringing together the globally diverse CRISPR community.
Dr. Barrangou currently serves as the Todd R. Klaenhammer Distinguished Scholar in Probiotics Research and Associate Professor of Food, Bioprocessing and Nutrition Sciences at North Carolina State University (NCSU). Born and educated in Paris, France, Dr. Barrangou moved to the United States for his post-graduate work. He is one of the early pioneers of CRISPR, having made major contributions during his years working at DuPont, prior to joining the NCSU faculty in 2013. Dr. Barrangou has published over 80 CRISPR papers since 2005, including the seminal 2007 study with Philippe Horvath and colleagues which presented the first experimental evidence that the bacterial CRISPR-Cas system provides adaptive immunity against viral infection.
Dr. Barrangou is the author of more than 120 peer-reviewed papers, and an inventor on over 40 issued and pending patents. He is the recipient of numerous prestigious scientific awards, including the 2016 Canada Gairdner International Award, the 2016 Warren Alpert Foundation Prize, and the 2017 National Academy of Sciences (NAS) Award in Molecular Biology. Dr. Barrangou also serves as a scientific advisor to several CRISPR-related biotechnology companies including Caribou Biosciences; he is a co-founder of Intellia Therapeutics and Locus Biosciences.
The CRISPR Journal will be the voice of the global CRISPR community and seeks to bring together researchers and practitioners in a wide range of disciplines, including genetics and genomics, cell biology, immunology, infectious diseases, microbiology, molecular biology, neuroscience, plant biology, ethics, and law. In addition to a broad selection of peer-reviewed research, the journal will feature an array of provocative front matter content including editorials, analyses, and commentary.
Dr. Barrangou will guide an established group of luminaries who have thrown their support behind the journal by joining the Editorial Board, including Jennifer Doudna (HHMI/UC Berkeley), Emmanuelle Charpentier (Max Planck Institute, Berlin), George Church (Harvard Medical School), Virginijus Siksnys (Vilnius Institute of Technology), and Eugene Koonin (NCBI).
The CRISPR Journal is actively considering research papers for its inaugural issue, which will be published in early 2018. Potential author inquiries can be sent to editorial@crisprjournal.com.
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.
